Safety Profile & Chemical Identity of Melanotan-2 Data from peer-reviewed publications and supplier datasheets Melanotan-2 Chemical Identity Synthetic cyclic heptapeptide analog of -MSH with lactam bridge Asp-Lys Melanotan-2 Documented Tolerance Profile Data from pilot clinical studies and peer-reviewed case reports Published clinical and preclinical data Four peer-reviewed trials and case reports Phase I pilot 1996, Wessells 1998-2000, case reports 2011-2014 2/3 Subjects with measurable pigmentation after 5 low doses of 0,01-0,03 mg/kg SC Doses studied (mg/kg SC) MC4R+ Central erectile function effects documented in double-blind crossover Evaluation method 20 years Cumulative review of Melanotan-I and Melanotan-II development since the University of Arizona Documented steps Case report Melanoma reported after Melanotan-2 injections + use of UV tanning beds Clinical context 3 generations Pharmacological evolution: MT2 (pan-MCR) bremelanotide (MC4R pref.) afamelanotide (MC1R selective) Receptor selectivity Important Notice Search Only Not intended for human consumption

With continued treatment and proper guidance, patients can experience gradual and steady weight loss while maintaining overall wellness
Here is the standard schedule mapped to a 10 mg vial reconstituted with 3 mL bacteriostatic water (3.33 mg/mL)
Eggs, chicken breasts, turkey, Greek yogurt, and beans are all good choices to boost protein consumption
GLP-1 patches refer to transdermal systems being studied for the delivery of glucagon-like peptide-1 receptor agonists, a class of medications that may support metabolic health by influencing insulin secretion and appetite regulation